Thomas F. Bumol

The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes

Gregory Gaich, Jenny Y. Chien, Haoda Fu et al. · Cell Metabolism · 2013 · 867 citations · Full text

Obesity, Metabolic Syndrome, Health Sciences +10

Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.

Anne H. Dantzig, Robert L. Shepard, Jin Cao et al. · PubMed · 1996 · 327 citations

Pharmaceutical Science, Pharmacotherapy, Chemical Biology +19

Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells.

Thomas F. Bumol, R. Reisfeld · Proceedings of the National Academy of Sciences · 1982 · 303 citations · Full text

Unique Glycoprotein-proteoglycan Complex, Glycobiology, Immunology +18

Simultaneous trimodal single-cell measurement of transcripts, epitopes, and chromatin accessibility using TEA-seq

Elliott Swanson, Cara Lord, Julian Reading et al. · eLife · 2021 · 252 citations · Full text

Genetics, Multiomics, Transcriptomics Technology +21

Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319

Alexei Kharitonenkov, John M. Beals, Radmila Micanovic et al. · PLoS ONE · 2013 · 163 citations · Full text

Human Growth, Cell Proliferation, Metabolic Remodeling +23